Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH.
JCO Oncol Pract. 2022 Nov;18(11):e1866-e1873. doi: 10.1200/OP.22.00412. Epub 2022 Oct 7.
The purpose of this study was to assess prostate-specific antigen (PSA) testing rates in persons experiencing homelessness (PEH), identify factors associated with screening, and compare PSA screening rates in PEH with a matched cohort of persons not experiencing homelessness (non-PEH).
We identified 9,249 potentially eligible PEH cared for at a large metropolitan hospital system from an institutional registry of all patients who presented to the health care system as homeless from 2014 to 2021. Homelessness was defined by the presence of the Z-code for homelessness (Z59), the listed address matching to the address of a homeless shelter or other transitional housing or a positive screen for homelessness. A matched cohort of 10,000 non-PEH was generated for comparison. Univariate chi-square analysis and multivariate logistic regression were performed to evaluate variables associated with PSA testing.
A total of 1,605 PEH and 3,413 non-PEH were eligible for PSA screening within the study timeframe. Half of PEH were Black (50%). Medicaid was the most common insurance (51%), followed by Medicare (18%). PEH were less likely to have a PCP (58% 81%, < .001) and had a significantly lower PSA testing rate (13% 34%, < .001) compared with non-PEH. Univariate analysis revealed that PSA testing was more common in PEH who were employed ( < .001), had private insurance or Medicare ( < .001), or had an established primary care provider (PCP; < .001). Multivariate analysis confirmed that having a PCP (OR, 2.54; 95% CI, 1.62 to 4.00; < .001) significantly increased the likelihood of PSA testing in PEH.
PEH experience low rates of prostate cancer screening. Interventions to increase screening in this population, including increased PCP access, are needed.
本研究旨在评估无家可归者(PEH)人群中的前列腺特异性抗原(PSA)检测率,确定与筛查相关的因素,并比较 PEH 和无家可归者(非 PEH)匹配队列的 PSA 筛查率。
我们从 2014 年至 2021 年,从一家为所有无家可归者提供医疗服务的医疗机构患者登记处中,确定了 9249 名可能符合条件的接受治疗的 PEH。无家可归是通过存在无家可归的 Z 代码(Z59)、列出的地址与无家可归者收容所或其他过渡性住房的地址匹配或对无家可归的阳性筛查来定义的。为了进行比较,生成了一个 10000 名非 PEH 的匹配队列。进行单变量卡方分析和多变量逻辑回归分析,以评估与 PSA 检测相关的变量。
在研究期间,共有 1605 名 PEH 和 3413 名非 PEH 有资格进行 PSA 筛查。一半的 PEH 是黑人(50%)。医疗保险是最常见的保险(51%),其次是医疗保险(18%)。PEH 更有可能没有初级保健提供者(PCP;58% 81%, <.001),并且 PSA 检测率明显较低(13% 34%, <.001)。与非 PEH 相比。单变量分析显示,在有工作的 PEH 中,PSA 检测更常见( <.001),有私人保险或医疗保险( <.001),或有固定的初级保健提供者(PCP; <.001)。多变量分析证实,有 PCP(OR,2.54;95%CI,1.62 至 4.00; <.001)显著增加了 PEH 进行 PSA 检测的可能性。
PEH 经历低水平的前列腺癌筛查。需要干预措施来增加该人群的筛查,包括增加 PCP 的机会。